Welcome to our dedicated page for Merit Med Sys SEC filings (Ticker: MMSI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how FDA approvals, product recalls, and R&D outlays sway Merit Medical Systems’ valuation can feel like surgery without anesthesia. The company’s annual report alone tops 250 pages, and every quarter another detailed 10-Q arrives with fresh data on catheter sales, embolization demand, and global logistics costs. If you’ve ever searched “Where can I find Merit Medical’s quarterly earnings report 10-Q filing?” or tried to decode footnotes on segment revenue, Stock Titan offers a precise remedy: AI-powered summaries that translate dense disclosures into plain language.
Our engine ingests each EDGAR submission the moment it posts—10-K, 10-Q, 8-K, Form 4, and the proxy—and converts them into actionable insights. Need “Merit Medical insider trading Form 4 transactions” before the bell? Real-time alerts flag every executive stock move. Curious about how warranty reserves changed after a material event? The platform’s AI links the note inside the filing and highlights the numbers. From high-level dashboards to paragraph-by-paragraph explanations, Stock Titan saves hours while keeping context intact.
Everything investors typically look for is one click away:
- “Merit Medical Form 4 insider transactions real-time” with historical charts
- “Merit Medical annual report 10-K simplified” sections on FDA risk and competitive landscape
- “Merit Medical proxy statement executive compensation” tables parsed into easy comparisons
- “Merit Medical 8-K material events explained” within minutes of release
- “Merit Medical earnings report filing analysis” that benchmarks quarter-over-quarter growth
- Guidance for understanding Merit Medical SEC documents with AI
Whether you monitor “Merit Medical executive stock transactions Form 4” ahead of product launches or study supply-chain commentary inside the 10-K, Stock Titan delivers complete coverage, AI clarity, and real-time speed.
Ashford Hospitality Trust, Inc. (NYSE: AHT) filed an 8-K on 11-Jul-2025 announcing that its Board has declared cash dividends on every outstanding series of its preferred stock.
- Quarterly dividends for Q3 2025, payable 15-Oct-2025 to holders of record 30-Sep-2025: Series D $0.5281; Series F $0.4609; Series G $0.4609; Series H $0.46875; Series I $0.46875.
- Monthly dividends (three payments each on 15-Aug, 15-Sep, 15-Oct-2025, record dates 31-Jul, 29-Aug, 30-Sep-2025): Series J $0.16667; Series K $0.17500, $0.17292 or $0.17083 depending on CUSIP; Series L $0.15625; Series M $0.16042.
- Outstanding shares as of 30-Jun-2025: Series J 7,699,923; Series K 747,299; Series L 112,181; Series M 145,232.
The information was furnished under Item 7.01 (Reg FD) and is therefore not considered “filed” for liability purposes.